Jelly-My-Jelly (JELLYJELLY) has surged 37.6% in the past 24 hours, reaching $0.112351 as trading volume spikes to $17.39 million.Jelly-My-Jelly (JELLYJELLY) has surged 37.6% in the past 24 hours, reaching $0.112351 as trading volume spikes to $17.39 million.

BREAKING: Jelly-My-Jelly Surges 37.6% to $0.112351 in 24 Hours

For feedback or concerns regarding this content, please contact us at [email protected]

Cryptocurrency token Jelly-My-Jelly (JELLYJELLY) has experienced a dramatic 37.6% price surge in the past 24 hours, reaching $0.112351 as of 5:22 AM UTC on March 6, 2026, according to live market data.

The token’s market capitalization has climbed to $112.8 million, marking a $30.75 million increase (37.5%) over the same period. JELLYJELLY now ranks #250 among all cryptocurrencies by market cap, with a fully diluted valuation matching its current market cap at $112.8 million.

Trading Volume Surges

Trading activity has intensified significantly, with 24-hour volume reaching $17.39 million. The token reached an intraday high of $0.112458 before settling slightly lower, after opening the day at $0.08123—representing a gain of 38.3% from its 24-hour low.

The price momentum extends beyond today’s session, with JELLYJELLY posting a 73.4% gain over the past week and an impressive 115.5% increase over the last 30 days. In the past hour alone, the token added another 2.6%, suggesting continued buying pressure.

Market Context

Despite the recent rally, JELLYJELLY remains 76.4% below its all-time high of $0.473157, reached on November 4, 2025. However, the token has gained 2,890% from its all-time low of $0.00372817, recorded on March 10, 2025.

The token’s circulating supply stands at 999,999,099.34 JELLYJELLY, which matches both its total and maximum supply, indicating no additional tokens will be minted.

What This Means for Traders

The substantial 24-hour price movement combined with elevated trading volume suggests significant market interest in JELLYJELLY. The consistency of gains across 1-hour, 24-hour, 7-day, and 30-day timeframes indicates sustained momentum rather than a brief spike.

Traders should note that while the token has posted strong gains, it remains well below previous highs, and the cryptocurrency market is known for volatility. The $17.39 million in daily trading volume represents approximately 15.4% of the token’s market cap, indicating active trading but potentially higher volatility risk.

Market participants should conduct thorough research and consider risk management strategies when trading volatile assets like JELLYJELLY.

Market Opportunity
jellyjelly Logo
jellyjelly Price(JELLYJELLY)
$0.083944
$0.083944$0.083944
+0.95%
USD
jellyjelly (JELLYJELLY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09